SCHEMBL131635

SCHEMBL131635

O[CH]c1ccc(F)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 3/20 0.50
PLA2G7 Q13093 2/20 0.42
TRPA1 O75762 1/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
PTGS2 P35354 1/20 0.39
RAB9A P51151 3/20 0.38
PABPC1 P11940 1/20 0.38
EIF4H Q15056 1/20 0.38
NPC1 O15118 3/20 0.38
MAPK1 P28482 1/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP1B1 Q16678 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15291312 0.80 NFE2L2 (0.57) NFE2L2PLA2G7TRPA1CES2CES1
SCHEMBL11127611 0.78 VCP (0.50) NFE2L2TRPA1RAB9ANPC1CYP1A2
SCHEMBL16954100 0.78 NFE2L2 (0.32) NFE2L2
SCHEMBL16956184 0.78 TRPA1 (0.46) TRPA1RAB9ANPC1MAPK1SMN1; SMN2
SCHEMBL16958944 0.78 GABRA1 (0.47) NFE2L2PTGS2
SCHEMBL16961237 0.78 TUBB1 (0.42) NFE2L2PTGS2ALDH1A1MAPTKMT2A
SCHEMBL16955558 0.78 KCNA3 (0.37) NFE2L2TRPA1MAPK1ALDH1A1MAPT
SCHEMBL16960237 0.78 KDM1A (0.37) NFE2L2TRPA1NPC1
SCHEMBL3299908 0.78 NFE2L2 (0.54) NFE2L2PLA2G7TRPA1CES2CES1
SCHEMBL29278542 0.75 TRPA1 (0.47) NFE2L2PLA2G7TRPA1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
US-8450319-B2 Pyrrolopyridazinone compound UBE INDUSTRIES, LTD. (JP) 2013-05-28 US disclosed
EP-1982986-B1 PYRROLOPYRIDAZINONE COMPOUND AS PDE4 INHIBITOR UBE INDUSTRIES (JP) 2012-03-07 EP disclosed
CN-101374844-A Pyrrolopyridazinone compound UBE INDUSTRIES (JP) 2009-02-25 CN disclosed
US-20090036453-A1 Pyrrolopyridazinone Compound UBE INDUSTRIES, LTD. (JP) 2009-02-05 US disclosed
EP-1982986-A1 PYRROLOPYRIDAZINONE COMPOUND Ube Industries, Ltd. (JP) 2008-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036453-A1 Pyrrolopyridazinone Compound CBR3, CBR1, CYC1 NFE2L2 708/4885PLA2G7 1017/4885TRPA1 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.